Ying-Ying Meng1, Allison Diamant2, Jenna Jones3, Wenjiao Lin4, Xiao Chen5, Shang-Hua Wu5, Nadereh Pourat6, Dylan Roby7, Gerald F Kominski6. 1. UCLA Center for Health Policy Research, Los Angeles, CA yymeng@ucla.edu. 2. UCLA Center for Health Policy Research, Los Angeles, CA Division of General Internal Medicine and Health Services Research, Department of Medicine, University of California, Los Angeles, Los Angeles, CA. 3. Truven Health Analytics, Washington, DC. 4. St. Jude Medical, Los Angeles, CA. 5. UCLA Center for Health Policy Research, Los Angeles, CA. 6. UCLA Center for Health Policy Research, Los Angeles, CA Department of Health Policy and Management, UCLA Fielding School of Public Health, Los Angeles, CA. 7. UCLA Center for Health Policy Research, Los Angeles, CA Department of Health Services Administration, University of Maryland School of Public Health, College Park, MD.
Abstract
OBJECTIVE: We examined the existence of disparities in receipt of appropriate diabetes care among California's fee-for-service Medicaid beneficiaries and the effectiveness of a telephonic-based disease management program delivered by a disease management vendor on the reduction of racial/ethnic disparities in diabetes care. RESEARCH DESIGN AND METHODS: We conducted an intervention-control cohort study to test the effectiveness of a 3-year-long disease management program delivered to Medicaid fee-for-service beneficiaries aged 22 to 75 with a diagnosis of diabetes in Los Angeles and Alameda counties. The outcome measures were the receipt of at least one hemoglobin A1c (HbA1c) test, LDL cholesterol test, and retinal examination each year. We used generalized estimating equations models with logit link to analyze the claims data for a cohort of beneficiaries in two intervention counties (n = 2,933) and eight control counties (n = 2,988) from September 2005 through August 2010. RESULTS: Racial/ethnic disparities existed in the receipt of all three types of testing in the intervention counties before the program. African Americans (0.66; 95% CI 0.62-0.70) and Latinos (0.77; 95% CI 0.74-0.80) had lower rates of receipt for HbA1c testing than whites (0.83; 95% CI 0.81-0.85) in the intervention counties. After the intervention, the disparity among African Americans and Latinos compared with whites persisted in the intervention counties. For Asian Americans and Pacific Islanders, the disparity in testing rates decreased. We did not find similar disparities in the control counties. CONCLUSIONS: This disease management program was not effective in reducing racial/ethnic disparities in diabetes care in the most racially/ethnically diverse counties in California.
OBJECTIVE: We examined the existence of disparities in receipt of appropriate diabetes care among California's fee-for-service Medicaid beneficiaries and the effectiveness of a telephonic-based disease management program delivered by a disease management vendor on the reduction of racial/ethnic disparities in diabetes care. RESEARCH DESIGN AND METHODS: We conducted an intervention-control cohort study to test the effectiveness of a 3-year-long disease management program delivered to Medicaid fee-for-service beneficiaries aged 22 to 75 with a diagnosis of diabetes in Los Angeles and Alameda counties. The outcome measures were the receipt of at least one hemoglobin A1c (HbA1c) test, LDL cholesterol test, and retinal examination each year. We used generalized estimating equations models with logit link to analyze the claims data for a cohort of beneficiaries in two intervention counties (n = 2,933) and eight control counties (n = 2,988) from September 2005 through August 2010. RESULTS: Racial/ethnic disparities existed in the receipt of all three types of testing in the intervention counties before the program. African Americans (0.66; 95% CI 0.62-0.70) and Latinos (0.77; 95% CI 0.74-0.80) had lower rates of receipt for HbA1c testing than whites (0.83; 95% CI 0.81-0.85) in the intervention counties. After the intervention, the disparity among African Americans and Latinos compared with whites persisted in the intervention counties. For Asian Americans and Pacific Islanders, the disparity in testing rates decreased. We did not find similar disparities in the control counties. CONCLUSIONS: This disease management program was not effective in reducing racial/ethnic disparities in diabetes care in the most racially/ethnically diverse counties in California.
Authors: Laura C Pinheiro; Orysya Soroka; Lisa M Kern; Noel Higgason; John P Leonard; Monika M Safford Journal: J Cancer Surviv Date: 2021-03-04 Impact factor: 4.442
Authors: Joel C Cantor; Sujoy Chakravarty; Jennifer Farnham; Jose Nova; Sana Ahmad; James H Flory Journal: Med Care Date: 2022-02-22 Impact factor: 3.178
Authors: Stephanie L Mayne; Luigi Loizzo; Michael P Bancks; Mercedes R Carnethon; Sharrelle Barber; Penny Gordon-Larsen; April P Carson; Pamela J Schreiner; Anne E Bantle; Kara M Whitaker; Kiarri N Kershaw Journal: Health Place Date: 2020-01-25 Impact factor: 4.931
Authors: Kevin M Pantalone; Anita D Misra-Hebert; Todd M Hobbs; Sheldon X Kong; Xinge Ji; Rahul Ganguly; Alex Milinovich; Wayne Weng; Janine M Bauman; Paul Petraro; Bartolome Burguera; Robert S Zimmerman; Michael W Kattan Journal: Diabetes Care Date: 2020-06-11 Impact factor: 19.112
Authors: William N Mkanta; Michelle C Reece; Abeer D Alamri; Emmanuel U Ezekekwu; Aishwarya Potluri; Neale R Chumbler Journal: Health Serv Res Manag Epidemiol Date: 2018-06-29
Authors: Sudipa Sarkar; Loren Lipworth; Edmond K Kabagambe; Aihua Bian; Thomas G Stewart; William J Blot; T Alp Ikizler; Adriana M Hung Journal: Front Nutr Date: 2020-05-21